Sonoma Pharmaceuticals, Inc.
SNOA
$1.10
-$0.03-2.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.18M | -3.37M | -3.48M | -3.56M | -3.46M |
| Total Depreciation and Amortization | 139.00K | 137.00K | 136.00K | 135.00K | 138.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -491.00K | 83.00K | 189.00K | 173.00K | 755.00K |
| Change in Net Operating Assets | -406.00K | -359.00K | 974.00K | 2.06M | 2.48M |
| Cash from Operations | -3.93M | -3.51M | -2.18M | -1.19M | -88.00K |
| Capital Expenditure | -192.00K | -210.00K | -165.00K | -181.00K | -80.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -192.00K | -210.00K | -165.00K | -181.00K | -80.00K |
| Total Debt Issued | 277.00K | 274.00K | 274.00K | 274.00K | 274.00K |
| Total Debt Repaid | -271.00K | -301.00K | -327.00K | -366.00K | -404.00K |
| Issuance of Common Stock | 471.00K | 359.00K | 883.00K | 2.43M | 3.16M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 477.00K | 332.00K | 830.00K | 2.34M | 3.03M |
| Foreign Exchange rate Adjustments | 673.00K | 712.00K | 472.00K | 52.00K | -616.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.98M | -2.68M | -1.04M | 1.02M | 2.25M |